MDI’s platform analyzes different factors to identify medication-related risks. The financing brings the company’s total funding to $26 million, according to a Feb. 14 MDI Health news release.
The company will use the financing to scale its product in the U.S. and Israel.
“With more patients and less staff, clinicians’ mission to deliver exceptional care has limitations. Clinicians are forced to make a judgment call when treating patients, leading to unnecessary medications, clinic visits, hospitalizations, and readmissions,” Intel Capital Managing Director Roi Bar-Kat said in the release. “MDI Health’s technology is a game changer for health plans and value-based providers, helping them deliver ‘whole’ person medication management, at scale — saving costs, and most importantly saving patients’ lives.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.